Patient Recruitment
Increase the probability of your trial design’s success with KerusCloud’s patient recruitment feature.
The KerusCloud® simulation tool is very powerful! The simulations for our pivotal trials showed us a suitable and straightforward path to reach marketing approval with a smaller number of patients and was quicker compared to our original plan.
Optimize Patient Recruitment with KerusCloud® Simulation
Patient recruitment remains one of the most critical and challenging aspects of clinical trial success. With KerusCloud®, you can simulate recruitment rates, test multiple scenarios, and optimize strategies before your study begins. By bridging operational planning with statistical rigor, KerusCloud® helps you reduce recruitment delays, minimize patient burden, and increase the probability of trial success—all in silico.
KerusCloud® helps you see how different recruitment strategies will play out—before your trial even begins. By simulating real-world scenarios across sites and timelines, it reveals challenges early and guides smarter decisions. The result: fewer delays, better resource planning, and a faster path to study success.
Explore the impact of different recruitment scenarios
Predict how long it will take to recruit the right patient population and how it will affect your timelines. With KerusCloud®, you can simulate multiple recruitment scenarios and gain an in-depth understanding of resulting challenges, so you can overcome barriers by adjusting your approach before your study’s launch.
Mimic common patient recruitment constraints
Customize your operational constraints to align with study objectives, business goals, and regulatory standards. KerusCloud® quantifies results from each recruitment decision and enables you to run simulations for multiple sites in different regions, exploring the impact of varying recruitment rates in each one. That way you can factor in recruitment alongside the other key study design choices you make, ensuring the best overall approach for study success.
Optimize your trial design for the best outcomes
Our drill down data visualizations allow you to explore the impact of your decisions and quickly understand how each recruitment profile influences your study’s success. So, you can make evidence-based choices to de-risk and optimize your clinical trial—reducing costs, development time, and patient burden.
Suggested For You
perspectives
April 20th, 2026
The FDA Drug Shortage List Signals Deeper Concerns for the US Medicine Supply Chain
perspectives
April 15th, 2026
Decision-Making in Early-Phase Oncology Trials: Navigating Uncertainty with Evidence Frameworks
perspectives
April 8th, 2026
Four Pillars of My Success as a Clinical Trial Transparency Specialist
webinar
March 26th, 2026
Making the Right Decisions With Incomplete Evidence in Early-Phase Oncology Trials
perspectives
March 25th, 2026
REMS and Labeling Are Strategic Design Decisions, Not Late-Stage Add-Ons
perspectives
March 12th, 2026
AI in Pharma: Autopilot Is Not the Same as Removing the Pilot
webinar
April 30th, 2026
Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors
perspectives
March 3rd, 2026
Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design
perspectives
February 25th, 2026
Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency
perspectives
February 10th, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
news
February 5th, 2026
MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions
perspectives
February 3rd, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development